http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0715627-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a14e5f153dd919df81ffc431befc4d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06Q50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06Q10-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q10-00
filingDate 2007-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a10a2366c10eb0e69f5f7ef850bcb48a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abc3ee126506883db64a668da531f68c
publicationDate 2013-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0715627-A2
titleOfInvention MEDICAL EVALUATION SUPPORT SYSTEM AND METHOD
abstract MEDICAL EVALUATION SUPPORT METHOD AND SYSTEM. The invention is directed to a medical evaluation support system. In one embodiment, a user enters a query that identifies an adverse event that a patient has experienced and the illnesses (illnesses, disorders, symptoms, conditions, etc.) that the patient has experienced. In response, the system causes one or more database searches to be performed to identify one or more possible causes of the adverse event for a patient with the identified diseases. In another embodiment, the user enters a combination of one or more drugs a patient has taken and one or more diseases the patient has suffered. The system operates to determine if there is an adverse event associated with the specified combination and reports any adverse events to the user. The system retains a copy of any comparison report for later searches to avoid reporting the same possible adverse event multiple times. The system performs any search in a predetermined program or may do so at the user's request. In another embodiment, the system integrates adverse event-drug-disease associations with electronic medical record (EMR) systems to identify, for healthcare providers or users, patients who may be potentially at risk from these adverse events.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017197476-A2
priorityDate 2006-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16204922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450446870

Total number of triples: 16.